Filing Details

Accession Number:
0001093557-20-000095
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 21:17:22
Reporting Period:
2020-03-11
Accepted Time:
2020-03-13 21:17:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1446422 Jeffrey Moy 6340 Sequence Drive
San Diego CA 92121
Evp Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-03-11 12,568 $0.00 26,651 No 4 J Direct
Common Stock Acquisiton 2020-03-11 12,568 $0.00 37,600 No 4 J Indirect by Trust
Common Stock Disposition 2020-03-11 81 $245.44 37,519 No 4 S Indirect by Trust
Common Stock Disposition 2020-03-11 166 $250.19 37,353 No 4 S Indirect by Trust
Common Stock Disposition 2020-03-11 5,956 $265.43 31,397 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 J Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
Footnotes
  1. Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.
  2. Included in this number are 26,651 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
  3. Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.
  4. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  5. This transaction was executed in multiple trades at prices ranging from $245.38 to $246.35. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  6. This transaction was executed in multiple trades at prices ranging from $250.12 to $250.23. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.